S&P 500   4,567.18 (-0.06%)
DOW   36,124.56 (-0.22%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.32%)
NIO   7.43 (+1.50%)
BABA   72.38 (-0.89%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.23 (-1.07%)
DIS   90.79 (-1.33%)
AMC   7.02 (-6.28%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
S&P 500   4,567.18 (-0.06%)
DOW   36,124.56 (-0.22%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.32%)
NIO   7.43 (+1.50%)
BABA   72.38 (-0.89%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.23 (-1.07%)
DIS   90.79 (-1.33%)
AMC   7.02 (-6.28%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
S&P 500   4,567.18 (-0.06%)
DOW   36,124.56 (-0.22%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.32%)
NIO   7.43 (+1.50%)
BABA   72.38 (-0.89%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.23 (-1.07%)
DIS   90.79 (-1.33%)
AMC   7.02 (-6.28%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
S&P 500   4,567.18 (-0.06%)
DOW   36,124.56 (-0.22%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.32%)
NIO   7.43 (+1.50%)
BABA   72.38 (-0.89%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.23 (-1.07%)
DIS   90.79 (-1.33%)
AMC   7.02 (-6.28%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)

Akebia Therapeutics (AKBA) Institutional Ownership

$1.12
-0.03 (-2.61%)
(As of 04:28 PM ET)
Compare
Today's Range
$1.11
$1.18
50-Day Range
$0.80
$1.17
52-Week Range
$0.28
$1.84
Volume
1.06 million shs
Average Volume
1.80 million shs
Market Capitalization
$211.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.50

Institutional Ownership Changes (13F Filings) for Akebia Therapeutics (NASDAQ:AKBA)

Current
Institutional Ownership
Percentage
27.04%
Number of
Institutional Buyers
(last 12 months)
24
Total
Institutional Inflows
(last 12 months)
$10.03 M
Number of
Institutional Sellers
(last 12 months)
19
Total
Institutional Outflows
(last 12 months)
$3.53 M
Get AKBA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Akebia Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

AKBA Institutional Buying and Selling by Quarter


Akebia Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2023Jacobs Levy Equity Management Inc.1,719,061$1.96M0.0%+27.7%0.913%
11/16/2023Creative Planning110,428$0.13M0.0%N/A0.059%
11/14/2023Qube Research & Technologies Ltd121,416$0.14M0.0%-72.2%0.064%
11/13/2023Northern Trust Corp302,121$0.34M0.0%-5.9%0.160%
11/13/2023Acadian Asset Management LLC7,223,488$8.23M0.0%-3.2%3.834%
11/13/2023FMR LLC638,090$0.73M0.0%+4.0%0.339%
11/9/2023Citigroup Inc.152,737$0.17M0.0%+311,608.2%0.081%
11/8/2023HighTower Advisors LLC95,350$0.11M0.0%+35.5%0.051%
11/6/2023Victory Capital Management Inc.755,488$0.86M0.0%+14.1%0.401%
8/15/2023XTX Topco Ltd339,367$0.31M0.1%N/A0.183%
8/14/2023State of Wyoming48,207$44K0.0%N/A0.026%
8/14/2023State Street Corp626,050$0.57M0.0%-9.6%0.337%
8/11/2023Renaissance Technologies LLC3,330,727$3.05M0.0%+42.4%1.791%
8/11/2023BlackRock Inc.2,736,856$2.50M0.0%+1.2%1.472%
8/11/2023Geode Capital Management LLC1,772,977$1.62M0.0%+5.4%0.954%
8/11/2023JPMorgan Chase & Co.37,903$35K0.0%-53.5%0.020%
8/11/2023Northern Trust Corp320,958$0.29M0.0%-13.8%0.173%
8/7/2023Acadian Asset Management LLC7,460,353$6.82M0.0%-0.3%4.012%
8/3/2023Mackenzie Financial Corp27,199$25K0.0%-34.3%0.015%
7/27/2023Victory Capital Management Inc.661,898$0.61M0.0%+156.8%0.356%
7/27/2023Virtu Financial LLC50,633$46K0.0%-48.3%0.027%
7/27/2023CWA Asset Management Group LLC49,000$45K0.0%+69.0%0.026%
7/19/2023Eudaimonia Partners LLC27,144$25K0.0%+123.5%0.015%
5/18/2023JPMorgan Chase & Co.81,547$45K0.0%+1,916.5%0.044%
5/16/2023Jane Street Group LLC46,193$26K0.0%-91.6%0.025%
5/16/2023State Street Corp692,836$0.39M0.0%+21.1%0.373%
5/15/2023Two Sigma Securities LLC138,037$77K0.0%+64.8%0.074%
5/15/2023Price T Rowe Associates Inc. MD105,500$60K0.0%-36.8%0.057%
5/15/2023Alerce Investment Management L.P.16,205,119$9.08M12.0%+7.4%8.716%
5/12/2023Renaissance Technologies LLC2,338,500$1.31M0.0%-19.0%1.258%
5/12/2023BlackRock Inc.2,703,523$1.52M0.0%-7.5%1.454%
5/12/2023Bank of America Corp DE193,459$0.11M0.0%+44.6%0.104%
5/12/2023Mirabella Financial Services LLP140,604$1.83M0.3%N/A0.076%
5/12/2023HRT Financial LP148,681$83K0.0%N/A0.080%
5/12/2023UBS Group AG87,975$49K0.0%+49.7%0.047%
5/12/2023Charles Schwab Investment Management Inc.79,804$45K0.0%-39.7%0.043%
5/12/2023HighTower Advisors LLC70,350$40K0.0%+18.4%0.038%
5/11/2023Icon Wealth Partners LLC50,000$28K0.0%N/A0.027%
5/10/2023Connor Clark & Lunn Investment Management Ltd.302,977$0.17M0.0%+152.4%0.163%
5/2/2023Victory Capital Management Inc.257,744$0.14M0.0%+1,200.3%0.140%
5/1/2023Virtu Financial LLC97,854$55K0.0%N/A0.053%
2/15/2023Public Employees Retirement System of Ohio149,945$87K0.0%-18.5%0.082%
2/15/2023Millennium Management LLC1,342,422$0.78M0.0%-61.4%0.730%
2/15/2023Alerce Investment Management L.P.15,090,119$8.71M10.0%+224.3%8.203%
2/14/2023Two Sigma Investments LP374,289$0.22M0.0%-30.3%0.203%
2/13/2023Renaissance Technologies LLC2,886,227$1.67M0.0%-4.3%1.569%
2/13/2023Geode Capital Management LLC1,682,498$0.97M0.0%+3.7%0.915%
2/10/2023Bank of America Corp DE133,764$77K0.0%-52.5%0.073%
2/10/2023Orchard Capital Management LLC66,826$39K0.0%-73.5%0.036%
2/10/2023Connor Clark & Lunn Investment Management Ltd.120,053$69K0.0%-76.5%0.065%
2/8/2023UBS Group AG58,755$34K0.0%-55.5%0.032%
11/15/2022Public Employees Retirement System of Ohio183,979$58K0.0%N/A0.100%
11/15/2022Jacobs Levy Equity Management Inc.2,042,816$0.65M0.0%+162.7%1.110%
11/15/2022Two Sigma Investments LP537,361$0.17M0.0%+151.6%0.292%
11/15/2022Vanguard Group Inc.13,182,865$4.17M0.0%-18.9%7.166%
11/15/2022Price T Rowe Associates Inc. MD166,900$54K0.0%+254.4%0.091%
11/15/2022Marshall Wace LLP314,316$0.10M0.0%N/A0.171%
11/15/2022Federated Hermes Inc.1,800,536$0.57M0.0%-9.5%0.979%
11/15/2022BlackRock Inc.4,286,956$1.36M0.0%-1.2%2.330%
11/14/2022Renaissance Technologies LLC3,016,427$0.95M0.0%+103.5%1.640%
11/14/2022Ergoteles LLC165,237$52K0.0%-80.5%0.090%
11/10/2022Connor Clark & Lunn Investment Management Ltd.510,102$0.16M0.0%+124.9%0.277%
11/10/2022Dimensional Fund Advisors LP627,549$0.20M0.0%-19.8%0.341%
10/26/2022Allspring Global Investments Holdings LLC242,866$76K0.0%+43.8%0.132%
10/26/2022Wipfli Financial Advisors LLC200,000$63K0.0%N/A0.109%
9/16/2022Federated Hermes Inc.1,989,467$0.70M0.0%-2.0%1.082%
8/18/2022Goldman Sachs Group Inc.341,546$0.12M0.0%-62.1%0.186%
8/17/2022Parallax Volatility Advisers L.P.109,683$39K0.0%-68.2%0.060%
8/15/2022AQR Capital Management LLC862,168$0.30M0.0%+367.4%0.469%
8/15/2022State Street Corp573,876$0.20M0.0%-95.0%0.312%
8/15/2022Millennium Management LLC5,354,175$1.89M0.0%+65.8%2.912%
8/13/2022Renaissance Technologies LLC1,482,300$0.52M0.0%+47.7%0.806%
8/12/2022Northern Trust Corp360,526$0.13M0.0%-78.5%0.196%
8/12/2022FMR LLC621,244$0.22M0.0%+177.3%0.338%
8/12/2022BNP Paribas Arbitrage SA90,540$32K0.0%+123.7%0.049%
8/12/2022Franklin Resources Inc.82,473$29K0.0%-32.6%0.045%
8/11/2022UBS Group AG130,652$46K0.0%-83.0%0.071%
8/10/2022Principal Financial Group Inc.414,392$0.15M0.0%+124.1%0.226%
8/5/2022Connor Clark & Lunn Investment Management Ltd.226,770$80K0.0%-51.9%0.124%
7/29/2022Russell Investments Group Ltd.225,640$78K0.0%-11.8%0.123%
7/25/2022Allspring Global Investments Holdings LLC168,942$59K0.0%-51.7%0.092%
7/19/2022Icon Wealth Partners LLC400,132$0.14M0.0%N/A0.218%
6/7/2022Bank of America Corp DE404,253$0.29M0.0%-11.9%0.220%
5/18/2022BNP Paribas Arbitrage SA40,474$29K0.0%-42.9%0.022%
5/17/2022Virtu Financial LLC130,949$94K0.0%N/A0.071%
5/17/2022Mirabella Financial Services LLP56,300$40K0.0%N/A0.031%
5/16/2022Goldman Sachs Group Inc.900,967$0.65M0.0%-58.0%0.491%
5/16/2022State Street Corp11,488,224$8.25M0.0%-2.2%6.259%
5/16/2022Orchard Capital Managment LLC1,762,731$1.27M0.4%+10.6%0.960%
5/16/2022Invesco Ltd.279,958$0.20M0.0%+47.1%0.153%
5/16/2022UBS Group AG769,438$0.55M0.0%+59.4%0.419%
5/13/2022Renaissance Technologies LLC1,003,327$0.72M0.0%+61.0%0.547%
5/13/2022Northern Trust Corp1,676,121$1.20M0.0%-4.0%0.913%
5/13/2022Charles Schwab Investment Management Inc.476,974$0.34M0.0%+7.4%0.260%
5/13/2022XTX Topco Ltd102,392$74K0.0%+282.7%0.056%
5/13/2022Prudential Financial Inc.249,912$0.18M0.0%-60.4%0.136%
5/13/2022Vanguard Group Inc.14,402,988$10.34M0.0%+8.8%7.848%
5/13/2022Dimensional Fund Advisors LP2,666,861$1.92M0.0%+2.8%1.453%
5/12/2022BlackRock Inc.13,961,540$10.02M0.0%-1.2%7.607%
5/12/2022MetLife Investment Management LLC85,186$61K0.0%+176.6%0.046%
(Data available from 1/1/2016 forward)













AKBA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of AKBA shares?

During the previous two years, 71 institutional investors and hedge funds held shares of Akebia Therapeutics. The most heavily invested institutionals were Alerce Investment Management L.P. ($9.08M), Acadian Asset Management LLC ($8.23M), Woodline Partners LP ($5.04M), Vanguard Group Inc. ($4.17M), Renaissance Technologies LLC ($3.05M), BlackRock Inc. ($2.50M), and Jacobs Levy Equity Management Inc. ($1.96M).Learn more on AKBA's institutional investors.

What percentage of Akebia Therapeutics stock is owned by institutional investors?

27.04% of Akebia Therapeutics stock is owned by institutional investors. Learn more on AKBA's institutional investor holdings.

Which institutional investors have been buying Akebia Therapeutics stock?

Of the 50 institutional investors that purchased Akebia Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Alerce Investment Management L.P. ($11.55M), Renaissance Technologies LLC ($3.39M), Millennium Management LLC ($2.12M), Jacobs Levy Equity Management Inc. ($1.64M), Vanguard Group Inc. ($1.17M), Victory Capital Management Inc. ($0.74M), and AQR Capital Management LLC ($0.68M).

How much institutional buying is happening at Akebia Therapeutics?

Institutional investors have bought a total of 28,139,004 shares in the last 24 months. This purchase volume represents approximately $17.51M in transactions.

Which Akebia Therapeutics major shareholders have been selling company stock?

Of the 41 institutional investors that sold Akebia Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: State Street Corp ($11.24M), Vanguard Group Inc. ($3.08M), Marshall Wace LLP ($2.49M), Millennium Management LLC ($2.14M), Goldman Sachs Group Inc. ($1.81M), Northern Trust Corp ($1.48M), and UBS Group AG ($0.71M).

How much institutional selling is happening at Akebia Therapeutics?

Institutional investors have sold a total of 29,895,957 shares in the last 24 months. This volume of shares sold represents approximately $19.74M in transactions.


This page (NASDAQ:AKBA) was last updated on 12/5/2023 by MarketBeat.com Staff

My Account -